SAFEs and convertible notes are fast ways to raise capital, but they are deceptively complex. Founders often underestimate the massive dilution that can occur when multiple notes convert, especially with post-money SAFEs. For investors, the risks include capital being trapped indefinitely or converting at unfavorable prices. The only way to manage these instruments is to model every scenario before you sign.
Key takeaways
- Always model your cap table to see how SAFEs convert in your next priced round.
- Understand the critical difference between pre-money and post-money SAFEs.
- Convertible notes have maturity dates; defaulting can bankrupt your company.
- An over-stacked SAFE round creates "cap table debt" that can spook Series A investors.
- Beware of MFN clauses in side letters that can retroactively worsen your terms.
- For investors, a high valuation cap on a SAFE is no guarantee of a good return.
Why Your SAFE Isn't Safe
Simple Agreements for Future Equity (SAFEs) and convertible notes feel like a godsend for early-stage fundraising. They let you raise cash quickly, avoid the painful process of pricing an early round, and get back to building your company. But this convenience hides a mountain of complexity. If you don't understand the mechanics, these "simple" instruments can cause crippling dilution, kill your next funding round, and even bankrupt your company.
Investors aren't immune either. They can see their capital trapped for years with no return or find that the terms they thought were great don't protect them at all. This is not a theoretical risk. It happens every day.
Forget the generic blog posts. This guide exposes the real risks from a founder and operator perspective. Here’s what you actually need to know.
The Founder's Guide to Not Messing This Up
For founders, the danger of SAFEs and notes boils down to one thing: un-managed dilution. You sign a few documents, the money hits your bank account, and you put the cap table implications out of mind. This is a critical error. You aren't just taking on cash; you're taking on "cap table debt" that will come due at your next priced round.
Mistake #1: The Post-Money SAFE Dilution Bomb
This is the single most important concept to understand. In the beginning, Y Combinator issued "pre-money" SAFEs. Now, the industry standard is the "post-money" SAFE. The difference sounds trivial. It is not.
Pre-Money SAFE: When these convert, the SAFE investors' money is added to the pre-money valuation of the priced round. This means all the SAFE investors dilute each other. The dilution is "shared." · Post-Money SAFE: The SAFE states a "Post-Money Valuation Cap." The investor's ownership is simply their investment divided by that cap. This insulates them from dilution by other SAFEs.
You decide to raise a $2M seed round using post-money SAFEs. You give the first $1M investor a SAFE with an $8M post-money cap. You give the second $1M investor the same SAFE with an $8M post-money cap.
In your head, you might do the math: "$2M on an $8M cap... that means $10M post-money, so I've sold 20%."
This is completely wrong. Each SAFE holder is guaranteed their ownership based on the cap.
Investor 1 is owed $1,000,000 / $8,000,000 = 12.5% of the company. · Investor 2 is owed $1,000,000 / $8,000,000 = 12.5% of the company.
Before you even start raising your Series A, you have already sold 25% of your company. The founders' and employees' stake has been diluted from 100% down to 75%. All of this happens before your new Series A investor even puts their money in, which will dilute you further. What you thought was 20% dilution was actually 25% + whatever your Series A costs you.
Stack enough of these, and you can show up to your Series A pitch having already given away 30-40% of the company. A savvy VC will see this and walk away, because there isn't enough equity left for the founders to stay motivated.
Mistake #2: The Convertible Note Ticking Time Bomb
A convertible note is debt. Unlike a SAFE, it has two components that can kill you: an interest rate and a maturity date .
Interest Rate: A typical note accrues 2% to 8% interest per year. This interest gets added to the principal and also converts to equity. It’s more dilution that you need to track. · Maturity Date: This is the real killer. A note typically matures in 18 to 24 months. If you have not raised a "qualified financing" (a priced round of a certain size, e.g., >$1M) by that date, the noteholders can demand immediate repayment of their principal plus all accrued interest.
If you can't pay, they can force your company into bankruptcy. While many investors will agree to extend the maturity date, they are not obligated to. A single disgruntled or nervous investor can pull the trigger and end your company.
Mistake #3: Ignoring Side Letters and MFN Clauses
Not all SAFEs are created equal. An investor may ask you to sign a "side letter" alongside the main SAFE document.
One of the most common clauses is a Most Favored Nation (MFN) provision. This states that if you later issue another SAFE or note to a different investor on better terms (e.g., a lower valuation cap), this investor automatically gets those better terms.
Imagine you give an early believer a $25k check on a SAFE with a $10M cap. Six months later, you're struggling to close the round and take $100k from a new investor at a $6M cap. Because of the MFN clause, that first investor's cap now drops from $10M to $6M, making their investment far more dilutive than you originally planned. It retroactively makes your early money more expensive.
Mistake #4: The Valuation Cap vs. Discount Trap
Most convertibles give an investor the better of two conversion prices: one based on the valuation cap, and one based on a discount to the priced round (typically 20%).
If your priced round valuation is HIGHER than the cap: The cap is used. E.g., $8M cap SAFE, $12M priced round. The SAFE converts at the $8M price. · If your priced round valuation is LOWER than the cap: The discount is used. E.g., $8M cap SAFE, $6M priced round. The investor gets a 20% discount, converting at a $4.8M valuation ($6M (1 - 0.20)).
Founders often forget to model the discount scenario, which can be even more dilutive in a down round or flat round.
The Investor's Guide to Not Losing Your Shirt
Investors take the primary risk: the startup fails, and their entire investment is a zero. But beyond that binary outcome, the structure of SAFEs and notes presents its own set of risks.
Risk #1: The "Zombie" SAFE
Because a SAFE has no maturity date, your capital can get stuck in limbo. If the company is a "zombie"—not dead, but not growing fast enough to raise a priced round—your money is trapped. There is no mechanism to force a conversion or a repayment. You can wait indefinitely for a liquidity event (like an acquisition) that may never happen.
Risk #2: The Cap Is Not a Promise
Investing in a SAFE with a high valuation cap can feel like you're getting a bad deal, but the alternative can be worse. If you invest on a SAFE with a $20M cap and a 20% discount, and the company ends up raising its Series A at a $15M pre-money valuation, your cap is irrelevant. You simply get the 20% discount and convert at a $12M valuation.
In this scenario, you took pre-seed or seed-stage risk but are effectively getting Series A terms. Your reward for being early is minimal. You missed out on the upside you could have captured with a lower cap.
Risk #3: The Over-Stacked Round Destroys Founder Incentive
Even a post-money SAFE designed to protect you has a hidden risk. If a founder issues too many of them, they can dilute themselves so much that they lose motivation. As an investor, the last thing you want is for the founders to effectively be working for you and the other investors. A clean cap table where the founders have a large, motivating stake is a huge asset for the company. A messy, over-leveraged one is a major red flag for the next round of investors.
How to Apply This Right Now
Build a "Shadow Cap Table" in a Spreadsheet. Create a simple spreadsheet. List every single SAFE and convertible note you have issued or plan to issue. Columns: Investor Name, Investment Amount, Valuation Cap, Discount %, Interest Rate (for notes), Date Signed. · Model the Series A Conversion. Create a hypothetical Series A scenario. Let's say, "$5M raise on a $20M pre-money valuation." Now, go through your list of convertibles one by one and calculate their conversion math. Figure out what percentage of the company each one will own. Sum it all up. · Stress-Test the Scenarios. Now, change the variables. What if your Series A is at a $10M pre-money (a down round)? What if it is at a $40M pre-money? See how the dilution changes. You will quickly see which notes are the most impactful and understand your true ownership. · Review Your Actual Documents. Pull up the signed PDFs. Are they pre-money or post-money? Did you sign a side letter with an MFN clause that you forgot about? You cannot rely on your memory. Verify the exact terms you agreed to.
SAFEs and convertible notes are powerful tools. But they are not "simple" or "safe." They demand your respect and attention. Do the math, understand the terms, and you can fund your company without giving it all away in the process.
Frequently asked questions
- What's the biggest mistake founders make with SAFEs?
- Not modeling the total dilution from multiple SAFEs. Founders often focus on each individual SAFE, not the compounding effect, and get a nasty surprise at their Series A.
- Is a post-money or pre-money SAFE better for founders?
- Pre-money SAFEs are generally more founder-friendly on dilution, as the dilution from multiple SAFEs is shared among all SAFE holders. However, the market standard is now the post-money SAFE, which you must understand thoroughly.
- Can a SAFE expire?
- Standard SAFEs (like the YC SAFE) do not expire or have a maturity date. This is a key difference from convertible notes, which have a maturity date when the debt can be called due.
- What is a typical valuation cap for a pre-seed round?
- It varies widely, but a typical range for a pre-seed or seed round might be $6M to $15M. A proven founding team with significant traction might command a higher cap, while a first-time founder with an idea might be on the lower end.
- How much dilution from SAFEs is 'too much' before a Series A?
- If your SAFEs and notes will convert to more than 20-25% of your company *before* the Series A round, new investors may hesitate. They need to see that the founders still own enough equity to be highly motivated.
